Mild cognitive impairment

Clinics in Geriatric Medicine

Volumn 20, Issue 1, 2004, Pages 15-25

  Bennett, David A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; GINKGO BILOBA EXTRACT;

AGING; ALZHEIMER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DIAGNOSTIC TEST; DISABILITY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MORBIDITY; MORTALITY; PREDICTION; PREVALENCE; PRIMARY PREVENTION; RELIGION; REVIEW; RISK FACTOR; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 1242270483     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2003.10.001     Document Type: Review

References (60)

1. Halsall P., editor. Internet ancient history sourcebook. Available at: http://www.fordham.edu/halsall/ancient/ptahhotep.html . Accessed November 28, 2003.
2. Alzheimer A. A characteristic disease of the cerebral cortex. Bick K., Amaducci L., Pepeu G. The early story of Alzheimer's disease. 1987;1-3 Liviana Editrice spa, Padova, Italy.
3. Wechsler D. The measurement and appraisal of adult intelligence. 4th edition:1958;Williams & Wilkins, Baltimore, MD.
4. Crum R.M., Anthony J.C., Bassett S.S., Folstein M.F. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 269:1993;2386-2391.
5. Williams J.G., Huppert F.A., Matthews F.E., Nickson J. Performance and normative values of a concise neuropsychological test (CAMCOG) in an elderly population sample. Int J Geriatr Psychiatry. 18:2003;631-644.
6. Welsh K.A., Butters N., Mohs R.C.et al. Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 44:1994;609-614.
7. Ganguli M., Ratcliff G., Huff F.J.et al. Effects of age, gender, and education on cognitive tests in a rural elderly community sample: norms from the Monongahela Valley Independent Elders Survey. Neuroepidemiology. 10:1991;42-52.
8. Lucas J.A., Ivnik R.J., Smith G.E.et al. Normative data for the Mattis Dementia Rating Scale. J Clin Exp Neuropsychol. 20:1998;536-547.
9. Wilson R.S., Beckett L.A., Bennett D.A., Albert M., Evans D.A. Change in cognitive function among older persons from a community population: relation to age and Alzheimer's disease. Archives of Neurology. 56:1999;1274-1279.
10. Wilson R.S., Beckett L.A., Barnes L.L.et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging. 17:2002;179-193.
11. Howieson D.B., Camicioli R., Quinn J.et al. Natural history of cognitive decline in the old old. Neurology. 60:2003;1489-1494.
12. Boeve B., McCormick J., Smith G.et al. Mild cognitive impairment in the oldest old. Neurology. 60:2003;477-480.
13. Kral V.A. Senescent forgetfulness: benign and malignant. Can Med Assn J. 86:1962;257-260.
14. Crook T., Bartus R.T., Ferris S.H.et al. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change. Dev Neuropsychol. 2:1986;261-276.
15. Jonker C., Hoyer C. The Amstel project: design and first findings. The course of mild cognitive impairment of the aged; a longitudinal 4-year study. Psychiatr J Univ Ott. 15:1990;207-211.
16. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 43:1993;2412-2414.
17. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol. 45:1999;358-368.
18. Morris J.C., Storandt M., Miller J.P.et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 58:2001;397-405.
19. Goldman W.P., Morris J.C. Evidence that age-associated memory impairment is not a normal variant of aging. Alzheimer Dis Assoc Disord. 15:2001;72-79.
20. Flicker C., Ferris S.H., Reisberg B. Mild cognitive impairment in the elderly: Predictors of dementia. Neurology. 41:1991;1006-1009.
21. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G.et al. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology. 56:1999;303-308.
22. Bennett D.A., Wilson R.S., Schneider J.A.et al. Natural history of mild cognitive impairment in older persons. Neurology. 59:2002;198-205.
23. Ebly E.M., Hogan D.B., Parhad I.M. Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol. 52:1995;612-619.
24. Petersen R.C., Doody R., Kurz A.et al. Current concepts in mild cognitive impairment. Arch Neurol. 58:2001;1985-1992.
25. Griffith H.R., Belue K., Sicola A.et al. Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology. 60:2003;449-457.
26. Mapstone M., Steffenella T.M., Duffy C.J. A visuospatial variant of mild cognitive impairment: getting lost between aging and AD. Neurology. 60:2003;802-808.
27. Ritchie K., Artero S., Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology. 56:2001;37-42.
28. Unverzagt F.W., Gao S., Baiyewu O.et al. Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology. 57:2001;1655-1662.
29. Graham J.E., Rockwood K., Beattie B.L.et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 349:1997;1793-1796.
30. Hanninen T., Hallikainen M., Tuomainen S., Vanhanen M., Soininen H. Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand. 106:2002;148-154.
31. Busse A., Bischkopf J., Riedel-Heller S.G., Angermeyer M.C. Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria. Results of the Leipzig Longitudinal Study of the Aged (LEILA75 +). Br J Psychiatry. 182:2003;449-454.
32. Storandt M., Grant E.A., Miller J.P., Morris J.C. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology. 59:2002;1034-1041.
33. Tuokko H., Frerichs R., Graham J.et al. I. Five-year follow-up of cognitive impairment with no dementia. Arch Neurol. 60:2003;577-582.
34. Gussekloo J., Westendorp R.G.J., Remarque E.J., Lagaay A.M., Heeren T.J., Knook D.L. Impact of mild cognitive impairment on survival in very elderly people: cohort study. Br Med J. 315:1997;1053-1054.
35. Frisoni G.B., Fratiglioni L., Fastbom J., Viitanene M., Winblad B. Mortality in nondemented subjects with coginitive impairment: the influence of health-related factors. Am J Epidemiol. 150:1999;1031-1044.
36. Artero S., Touchon J., Ritchie K. Disability and mild cognitive impairment: a longitudinal population-based study. Int J Geriatr Psychiatry. 16:2001;1092-1097.
37. Tierney M.C., Szalai J.P., Snow W.G.et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology. 46:1996;661-665.
38. Flicker C., Ferris S.H., Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 41:1991;1006-1009.
39. Devanand D.P., Folz M., Gorlyn M., Moeller J.R., Stern Y. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc. 45:1997;321-328.
40. Daly E., Zaitchik D., Copeland M., Schmahmann J., Gunther J., Albert M. Predicting conversion to Alzheimer disease using standardized clinical information. Arch Neurol. 57:2000;675-680.
41. Bowen J., Teri L., Kukull W., McCormick W., McCurry S.M., Larson E.B. Progression to dementia in patients with isolated memory loss. Lancet. 349:1997;763-765.
42. Larrieu S., Letenneur L., Orgogozo J.M.et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 59:2002;1594-1599.
43. Tabert M.H., Albert S.M., Borukhova-Milov L.et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology. 58:2002;758-764.
44. Devanand D.P., Michaels-Marston K.S., Liu X.et al. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry. 157:2000;1399-1405.
45. Dickerson B.C., Goncharova I., Sullivan M.P.et al. MRI -derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging. 22:2001;747-754.
46. Jack C.R. Jr., Petersen R.C., Xu Y.C.et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 52:1999;1397-1403.
47. Arnaiz E., Jelic V., Almkvist O.et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport. 12:2001;851-855.
48. Riemenschneider M., Lautenschlager N., Wagenpfeil S., Diehl J., Drzezga A., Kurz A. Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol. 59:2002;1729-1734.
49. de Leon M.J., Segal S., Tarshish C.Y.et al. Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neurosci Lett. 333:2002;183-186.
50. Okamura N., Arai H., Maruyama M.et al. Combined Analysis of CSF tau levels and [(123)I]Iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer's disease. Am J Psychiatry. 159:2002;474-476.
51. Schneider J.A., Wilson R.S., Cochran E.J.et al. Relation of cerebral infarctions to dementia and cognitive function in older person. Neurology. 60:2003;1082-1089.
52. Bennett D.A., Wilson R.S., Schneider J.A.et al. Apolipoprotein E4 allele, Alzheimer's disease pathology, and the clinical expression of Alzheimer's disease. Neurology. 60:2003;246-252.
53. DeKosky S.T., Ikonomovic M., Styren S.et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 51:2002;145-155.
54. Mufson E.J., Chen E.Y., Cochran E.J., Beckett L.A., Bennett D.A., Kordower J.H. Entorhinal cortex β-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 158:1999;469-490.
55. Mitchell T.W., Mufson E.J., Schneider J.A.et al. Parahippocampal tau pathology in healthy aging, mild cognitive impairment and early Alzheimer's disease. Ann Neurol. 51:2002;182-189.
56. Ghoshal N., Garcia-Sierra F., Wuu J.et al. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol. 177:2002;475-493.
57. Kordower J.H., Chu Y., Stebbins G.T.et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol. 49:2001;202-213.
58. Palmer K., Backman L., Winblad B., Fratiglioni L. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. Br Med J. 326:2003;245-249.
59. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 56:2001;1133-1142.
60. Doody R.S., Stevens J.C., Beck C.et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 56:2001;1154-1166.